FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300690568> ?p ?o ?g. }

• W4300690568 endingPage "2307" @default.
• W4300690568 startingPage "2298" @default.
• W4300690568 abstract "The drug 3-n-butylphthalide (NBP) was developed and approved in China, where it has been used to treat ischemic cerebrovascular diseases. It is also considered to have a neuroprotective effect. This study aimed to evaluate whether NBP combined with endovascular treatment (EVT) can improve the clinical outcome and safety in patients with acute ischemic stroke (AIS) due to large vessel occlusion (LVO).Data from three studies of patients treated with EVT for AIS due to LVO were combined in this study. Patients of LVO undergoing EVT were dichotomized into NBP and non-NBP subgroups. The primary efficacy outcome was the shift of the modified Rankin Scale (mRS) score at 90 days. The secondary efficacy outcome included favorable functional outcomes, functional independence, and excellent outcome (defined as an mRS score of 3 or less) at 90 days. Safety outcomes included mortality within 90 days and symptomatic intracranial hemorrhage (sICH) within 48 h.A total of 1820 patients undergoing EVT were included in this study; 628 (37.5%) patients received NBP treatment, whereas 1138 (62.5%) did not. After adjusting for multiple factors, NBP was associated with the improvement of functional outcomes at 90 days (adjusted common odds ratio [OR]: 1.503; 95% confidence interval (CI): 1.254-1.801; p < 0.001). NBP was associated with a higher rate of 90-day favorable outcomes (adjusted OR: 1.589; 95% CI: 1.251-2.020; p < 0.001) and a lower rate of 90-day mortality (adjusted OR: 0.486 [95% CI: 0.372-0.635]; p < 0.001). sICH occurred in 74 of 682 (10.9%) patients in the NBP group and 155 of 1126 (13.8%) patients in the non-NBP group; no statistical difference was detected (adjusted OR: 0.787 [95% CI: 0.567-1.092]; p = 0.152).Among patients with AIS due to LVO, NBP combined with EVT is associated with better functional outcomes and reduced mortality risk without increasing the risk of sICH." @default.
• W4300690568 created "2022-10-04" @default.
• W4300690568 creator A5003910501 @default.
• W4300690568 creator A5004488211 @default.
• W4300690568 creator A5009088969 @default.
• W4300690568 creator A5011153092 @default.
• W4300690568 creator A5018005107 @default.
• W4300690568 creator A5021741896 @default.
• W4300690568 creator A5028432518 @default.
• W4300690568 creator A5049356885 @default.
• W4300690568 creator A5051644936 @default.
• W4300690568 creator A5059893966 @default.
• W4300690568 creator A5065155009 @default.
• W4300690568 creator A5078752570 @default.
• W4300690568 creator A5080010553 @default.
• W4300690568 creator A5088695098 @default.
• W4300690568 date "2022-10-02" @default.
• W4300690568 modified "2023-09-27" @default.
• W4300690568 title "Efficacy and safety of <scp>3‐n‐butylphthalide</scp> combined with endovascular treatment in acute ischemic stroke due to large vessel occlusion" @default.
• W4300690568 cites W2155915103 @default.
• W4300690568 cites W2277258071 @default.
• W4300690568 cites W2296269595 @default.
• W4300690568 cites W2350815091 @default.
• W4300690568 cites W2588744471 @default.
• W4300690568 cites W2734567507 @default.
• W4300690568 cites W2765413914 @default.
• W4300690568 cites W2800425544 @default.
• W4300690568 cites W2802720163 @default.
• W4300690568 cites W2803728669 @default.
• W4300690568 cites W2810861785 @default.
• W4300690568 cites W2911054292 @default.
• W4300690568 cites W2924456233 @default.
• W4300690568 cites W2937207463 @default.
• W4300690568 cites W2946807339 @default.
• W4300690568 cites W2951428841 @default.
• W4300690568 cites W2953950059 @default.
• W4300690568 cites W2954072343 @default.
• W4300690568 cites W2966439723 @default.
• W4300690568 cites W2977352716 @default.
• W4300690568 cites W2985214247 @default.
• W4300690568 cites W2988944365 @default.
• W4300690568 cites W2996061133 @default.
• W4300690568 cites W3128112012 @default.
• W4300690568 cites W3159527830 @default.
• W4300690568 cites W3168006058 @default.
• W4300690568 cites W3217761785 @default.
• W4300690568 cites W4206201161 @default.
• W4300690568 cites W4300690568 @default.
• W4300690568 doi "https://doi.org/10.1111/cns.13978" @default.
• W4300690568 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36184804" @default.
• W4300690568 hasPublicationYear "2022" @default.
• W4300690568 type Work @default.
• W4300690568 citedByCount "2" @default.
• W4300690568 countsByYear W43006905682022 @default.
• W4300690568 countsByYear W43006905682023 @default.
• W4300690568 crossrefType "journal-article" @default.
• W4300690568 hasAuthorship W4300690568A5003910501 @default.
• W4300690568 hasAuthorship W4300690568A5004488211 @default.
• W4300690568 hasAuthorship W4300690568A5009088969 @default.
• W4300690568 hasAuthorship W4300690568A5011153092 @default.
• W4300690568 hasAuthorship W4300690568A5018005107 @default.
• W4300690568 hasAuthorship W4300690568A5021741896 @default.
• W4300690568 hasAuthorship W4300690568A5028432518 @default.
• W4300690568 hasAuthorship W4300690568A5049356885 @default.
• W4300690568 hasAuthorship W4300690568A5051644936 @default.
• W4300690568 hasAuthorship W4300690568A5059893966 @default.
• W4300690568 hasAuthorship W4300690568A5065155009 @default.
• W4300690568 hasAuthorship W4300690568A5078752570 @default.
• W4300690568 hasAuthorship W4300690568A5080010553 @default.
• W4300690568 hasAuthorship W4300690568A5088695098 @default.
• W4300690568 hasBestOaLocation W43006905682 @default.
• W4300690568 hasConcept C126322002 @default.
• W4300690568 hasConcept C127413603 @default.
• W4300690568 hasConcept C141071460 @default.
• W4300690568 hasConcept C156957248 @default.
• W4300690568 hasConcept C2776098176 @default.
• W4300690568 hasConcept C2776268601 @default.
• W4300690568 hasConcept C2780645631 @default.
• W4300690568 hasConcept C2780931571 @default.
• W4300690568 hasConcept C3018386432 @default.
• W4300690568 hasConcept C3020199598 @default.
• W4300690568 hasConcept C44249647 @default.
• W4300690568 hasConcept C541997718 @default.
• W4300690568 hasConcept C71924100 @default.
• W4300690568 hasConcept C78519656 @default.
• W4300690568 hasConceptScore W4300690568C126322002 @default.
• W4300690568 hasConceptScore W4300690568C127413603 @default.
• W4300690568 hasConceptScore W4300690568C141071460 @default.
• W4300690568 hasConceptScore W4300690568C156957248 @default.
• W4300690568 hasConceptScore W4300690568C2776098176 @default.
• W4300690568 hasConceptScore W4300690568C2776268601 @default.
• W4300690568 hasConceptScore W4300690568C2780645631 @default.
• W4300690568 hasConceptScore W4300690568C2780931571 @default.
• W4300690568 hasConceptScore W4300690568C3018386432 @default.
• W4300690568 hasConceptScore W4300690568C3020199598 @default.
• W4300690568 hasConceptScore W4300690568C44249647 @default.
• W4300690568 hasConceptScore W4300690568C541997718 @default.
• W4300690568 hasConceptScore W4300690568C71924100 @default.

• next